The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression-Reference-Cited by-同舟云学术

The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression

Published:2022-08-29 Issue:4 Volume:26 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Trtkova Katerina¹,Luzna Petra¹,Drozdkova Denisa¹,Cizkova Katerina²,Janovska Lucie³,Gursky Jan⁴,Prukova Dana⁵,Frydrych Ivo⁶,Hajduch Marian⁶,Minarik Jiri⁷

Affiliation:

1. Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, 777 15 Olomouc, Czech Republic

2. Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University Olomouc, 777 15 Olomouc, Czech Republic

3. Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, 777 15 Olomouc, Czech Republic

4. Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, 777 15 Olomouc, Czech Republic

5. Institute of Pathological Physiology, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic

6. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, 779 00 Olomouc, Czech Republic

7. Department of Hemato‑Oncology, University Hospital Olomouc, 779 00 Olomouc, Czech Republic

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference64 articles.

1. Pathogenesis beyond the cancer clone(s) in multiple myeloma;Bianchi;Blood,2015

2. Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma;Abe;Int J Hematol,2011

3. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance;Meads;Clin Cancer Res,2008

4. Molecular pathogenesis of multiple myeloma;Furukawa;Int J Clin Oncol,2015

5. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma;Harmer;Front Endocrinol (Lausanne),2019